| IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase–driven tumors KL Jameson, PK Mazur, AM Zehnder, J Zhang, B Zarnegar, J Sage, ... Nature medicine 19 (5), 626-630, 2013 | 229 | 2013 |
| Genetic pathways in disorders of epidermal differentiation V Lopez-Pajares, K Yan, BJ Zarnegar, KL Jameson, PA Khavari Trends in Genetics 29 (1), 31-40, 2013 | 114 | 2013 |
| Identification of novel and conserved functional and structural elements of the G1 cyclin Cln3 important for interactions with the CDK Cdc28 in Saccharomyces cerevisiae ME Miller, FR Cross, AL Groeger, KL Jameson Yeast 22 (13), 1021-1036, 2005 | 20 | 2005 |
| Identification of NSCLC biomarkers underlying quantifiable drug-induced clonal fitness KL Jameson, PL Frick, DR Tyson, TE Yankeelov, V Quaranta Cancer Research 75 (15_Supplement), 3747-3747, 2015 | | 2015 |
| Quantitative PET and MRI to monitor tumor growth and treatment response in hollow fiber bioreactors. SD Rani, KL Jameson, J Hao, DC Colvin, DR Tyson, J Fellenstein, ... JOURNAL OF NUCLEAR MEDICINE 56 (2), 15-15, 2015 | | 2015 |
| Sensitivity of PC9 cells to erlotinib is affected by extracellular matrix HM Onishko, J Zhao, KL Jameson, PL Frick, DR Tyson, V Quaranta, ... Cancer Research 74 (19_Supplement), 1845-1845, 2014 | | 2014 |
| SCAFFOLD-KINASE INTERACTION BLOCKADES AND USES THEREOF IN TREATING CANCER KL JAMESON, PA KHAVARI, THEBOFTOFTHELS UNIVERSITY WO Patent 2,012,170,113, 2012 | | 2012 |
| Scaffold-Kinase interaction blockade selectively inhibits Ras-MAPK tumorigenesis KL Jameson, A Zehnder, PA Khavari JOURNAL OF INVESTIGATIVE DERMATOLOGY 132, S30-S30, 2012 | | 2012 |
| Abstract A49: The ERK/MAPK scaffold IQGAP1 is a tumor-selective target KL Jameson, AM Zehnder, PA Khavari Cancer Research 71 (18_Supplement), A49-A49, 2011 | | 2011 |
| Tumor Selective Targeting of a Conserved Scaffold Domain KLR Jameson Stanford University, 2011 | | 2011 |
| Science & Society JO Yáñez-Cuna, EZ Kvon, A Stark, H Kilpinen, JC Barrett, ... | | |
